Enlivex Therapeutics
ENLV
ENLV
5 hedge funds and large institutions have $1.36M invested in Enlivex Therapeutics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$632K |
| 2 |
Renaissance Technologies
New York
|
+$104K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$43.8K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$3K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $635K | +$104K | +3,900 | +20% |
|
|
2
Jane Street
New York
| $632K | +$632K | +23,655 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $85K | +$43.8K | +1,641 | +107% |
|
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3K | +$3K | +125 | New |
|